Device Trial Radar · NCT05572047
Coherent Sine Burst (CSE) Electroporation System Pilot Study in Patients With Atrial Fibrillation
Last checked: Nov 20, 2026Latest source record: Oct 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
101
Actual
Start
Oct 11, 2022
Primary completion
Apr 24, 2026
Study completion Apr 24, 2026
Sponsor
- Lead sponsor
- Arga Medtech SANot on our public-company list
- Sponsor type
- Industry
- First posted
- Oct 7, 2022
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To evaluate the safety and efficiency of the Arga Medtech CSE Ablation System in the treatment of atrial fibrillation.
Conditions
- Atrial Fibrillation
Interventions
Arga Medtech Coherent Sine-Burst Electroporation (CSE) Ablation SystemDevice
Use of coherent sine-burst electroporation to ablate paroxysmal and persistent AF
Primary outcomes
What the sponsor says the trial is designed to measure.
- Serious system and procedure-related eventsTime frame: Within one week (7 days) post-procedure)
- Procedural SuccessTime frame: Acute and/or up to 90 days post procedure
- Chronic isolation of the pulmonary veinsTime frame: 90 to 180 days post index procedure
Locations
3 sites in 2 countries. Site status is shown where the registry gives one.
University Hospital of Split
Split, Croatia
KBC Zagreb
Zagreb, Croatia
Israeli-Georgian Medical Research Clinic Helthycore Ltd
Tbilisi, Georgia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.